Fig. 2
From: Mesenchymal stem cells: a novel therapeutic approach for feline inflammatory bowel disease
MSCs improve clinical signs of feline IBD. (a) Feline IBD-like injury treatment procedures; (b) Monitoring of body weight as an indicator of efficacy; (c) Assessment of fecal scores reflecting intestinal health; (d) Endoscopic observation of the colonic mucosa before and after MSC treatment; (e) Histopathological examination of colonic tissues after MSC intervention; (f) Quantitative analysis of serum levels of inflammatory cytokines; (g) Immunohistochemical staining of the colon showing MSCs’ protective effects of MSCs on the intestinal barrier; (h) Expression levels and relative quantification of colonic barrier proteins. Significant variations had been denoted with * (p < 0.05), ** (p < 0.01), or *** (p < 0.001)